All hip replacements come with risks, including dislocation and wear and tear, but the study for The Lancet found that these specific makes have a higher level of risk.

The study showed that 6.2% of metal hip replacements failed within the first five year, which is in comparison to 1.7% for plastic ones and 2.6% for ceramic. The data came from England and Wales’ National Joint Registry.

The risk was found to be greater in women.

Concerns over the metal implants began a few weeks ago, after it was found that parts of the metal hip replacements were breaking off and finding its way into the bloodstream, causing bone, muscle and neurological issues.

The number of patients receiving these implants has fallen rapidly in the last few years: 8,072 were fitted in 2008, in comparison to 673 in 2011.

Following the release of the data, Dr Susanne Ludgate of the UK's Medicines and Healthcare products Regulatory Agency (MHRA) said, "We recognise that there is emerging evidence of increased revision rates associated with large head metal on metal hip replacements. But the clinical evidence is mixed and this does not support their removal from the market.

"We will take quick action if we need to and, if patients have any questions, they should speak to their orthopaedic surgeon or doctor."